scholarly journals Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment

Diabetes Care ◽  
2017 ◽  
Vol 40 (8) ◽  
pp. 1103-1110 ◽  
Author(s):  
Kevin K.W. Olesen ◽  
Morten Madsen ◽  
Gro Egholm ◽  
Troels Thim ◽  
Lisette O. Jensen ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Real World ◽  
Prophylactic Treatment ◽  
World Population ◽  
Patients With Diabetes ◽  
Artery Disease

scholarly journals Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]

2019 ◽  
Vol Volume 11 ◽  
pp. 721-722 ◽  
Author(s):  
Kevin Kris Warnakula Olesen ◽  
Christine Gyldenkerne ◽  
Morten Madsen ◽  
Troels Thim ◽  
Lisette Okkels Jensen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Patients With Diabetes ◽  
Artery Disease

scholarly journals Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus

2019 ◽  
Vol Volume 11 ◽  
pp. 419-428 ◽  
Author(s):  
Christine Gyldenkerne ◽  
Kevin Kris Warnakula Olesen ◽  
Morten Madsen ◽  
Troels Thim ◽  
Lisette Okkels Jensen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Patients With Diabetes ◽  
Artery Disease

Abluminus DES+ for the treatment of coronary artery disease in patients with diabetes mellitus

2020 ◽  
Author(s):  
Ridhima Goel ◽  
Rishi Chandiramani ◽  
Roxana Mehran
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Clinical Outcomes ◽  
Coronary Intervention ◽  
World Population ◽  
Global Epidemic ◽  
Patients With Diabetes ◽  
Artery Disease ◽  
Sirolimus Eluting Stent

Diabetes mellitus (DM) is a rising global epidemic affecting more than 10% of the world population and predisposes patients to develop highly progressive and complex coronary artery disease. Despite numerous advancements in percutaneous coronary intervention procedural techniques and coronary stent platforms, clinical outcomes in DM patients have improved little compared with non-DM patients. Abluminus DES+, a biodegradable polymer sirolimus-eluting stent deployed with a drug-coated balloon, has been specifically designed to provide adequate coverage for DM patients and reduce adverse clinical outcomes.

scholarly journals A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literature

2013 ◽  
Vol 2013 ◽  
Author(s):  
M S Draman ◽  
H Thabit ◽  
T J Kiernan ◽  
J O'Neill ◽  
S Sreenan ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Myocardial Ischaemia ◽  
Annual Review ◽  
List Type ◽  
Silent Myocardial Ischaemia ◽  
Objective Evidence ◽  
Patients With Diabetes ◽  
Artery Disease

Summary Silent myocardial ischaemia (SMI), defined as objective evidence of myocardial ischaemia in the absence of symptoms, has important clinical implications for the patient with coronary artery disease. We present a dramatic case of SMI in a diabetes patient who attended annual review clinic with ST elevation myocardial infarction. His troponin was normal on admission but raised to 10.7 ng/ml (normal <0.5) when repeated the next day. His angiogram showed diffused coronary artery disease. We here discuss the implications of silent ischaemia for the patient and for the physician caring for patients with diabetes. Learning points Silent myocardial ischaemia (SMI) is an important clinical entity. SMI is common and occurs with increased frequency in patients with diabetes. SMI is an independent predictor of mortality. Recognition may lead to early intervention.

Sign in / Sign up

Export Citation Format

Share Document